This guideline applies to human medicines.
This document provides general guidance on the stability data which have to be generated in order to support a variation to a marketing authorisation. It provides general guidance on stability testing for type IA and type IB variations and addresses the data requirements for common type II variations.
Keywords: Stability, stability testing, stability data, chemical active substance, specification, variation